Table 3 Comparison of laboratory parameters between treatment groups during the study
Variable | Group | Pre-test | Post-test | p value | Within-group p value |
|---|---|---|---|---|---|
Blood glucose (mg/dl) | Intervention group | 112.56 ± 8.31 | 109.54 ± 8.69 | 0.23 | p = .005 |
Comparison group | 112.9 ± 8.65 | 107.70 ± 10.81 | p = .001 | ||
Between-group p value | 0.84 | 0.35 | |||
Total cholesterol (mg/dl) | Intervention group | 209.48 ± 14.42 | 180.68 ± 14.51 | 0.71 | p < .001 |
Comparison group | 206.28 ± 6.61 | 180.12 ± 7.50 | p < .001 | ||
Between-group p value | 0.157 | 0.809 | |||
Triglyceride (mg/dl) | Intervention group | 148.22 ± 18.52 | 110.06 ± 19.35 | 0.73 | p < .001 |
Comparison group | 145.98 ± 19.88 | 106 ± 13.96 | p < .001 | ||
Between-group p value | 0.56 | 0.23 | |||
HDL (mg/dl) | Intervention group | 46.46 ± 4.01 | 48.98 ± 4.32 | 0.48 | p < .001 |
Comparison group | 46.50 ± 6.90 | 49.58 ± 6.63 | p < .001 | ||
Between-group p value | 0.97 | 0.59 | |||
LDL (mg/dl) | Intervention group | 133.94 ± 4.85 | 111.42 ± 6.37 | 0.1 | p < .001 |
Comparison group | 132.52 ± 3.44 | 111.26 ± 10.67 | p < .001 | ||
Between-group p value | 0.09 | 0.92 | |||
AST (mg/dl) | Intervention group | 44.14 ± 16.67 | 37.72 ± 8.45 | 0.06 | p = .026 |
Comparison group | 43.52 ± 11.52 | 41.06 ± 8.42 | p = .036 | ||
Between-group p value | 0.83 | 0.051 | |||
ALT (mg/dl) | Intervention group | 64.02 ± 22.26 | 48.12 ± 11.52 | 0.012 | p < .001 |
Comparison group | 59.60 ± 19.07 | 53.52 ± 14.02 | p < .001 | ||
Between-group p value | 0.28 | 0.038 |